Ian Copple

(BBSRC NWD CASE) Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities at University of Liverpool on FindAPhD.com PhD Project - (BBSRC NWD CASE) Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities at University of Liverpool, listed on FindAPhD...

📢 Fully funded PhD opportunity in my group!

Project title: Unravelling the origins, mechanisms and implications of species differences in cellular stress response pathway capacities.

Application deadline: 7 December 2025.

Details/apply: tinyurl.com/2jcp9jfz

Questions: Get in touch!

Earlier this month I had a fantastic time in Galway, Ireland attending the SFRRI biennial meeting and the @benbedphar.bsky.social satellite meeting. Nice to catch up with friends and colleagues, including the 'Godfather' of the NRF2 field Masi Yamamoto!

Outstanding talk by @parikki.bsky.social , recipient of the CATHERINE PASQUIER AWARD LECTURE at SFFR-I Biennial Meeting in Galway @uniofgalway.bsky.social.

Are ROS generated in nanodomains / condensates in cells?

Want to know more, please read her paper
lnkd.in/dq_6Rnaw

@sfrre-ecr.bsky.social

Liverpool's @parikki.bsky.social giving the Catherine Pasquier Award lecture at the SFRRI Biennial Meeting in Galway. Fantastic talk 👏🏻

@liverpooluni.bsky.social @livuni-ismib.bsky.social
@livunihls.bsky.social

A huge well done to group member Hannah Coghlan for passing her PhD viva today. It's been a pleasure to work with Hannah over the past 4 years, she deserves all of her success. Congratulations Dr Coghlan 🍾🎉👏🏻

Big congratulations to group member Hannah Coghlan for winning a poster prize at the British Toxicology Society annual meeting. Very well done 👏🏻

Fantastic presentation from group member Olivia Harris as part of the selected oral communications session at the British Toxicology Society annual congress.

After months of preparation, we're finally ready to kick off the British Toxicology Society annual congress in Liverpool. Thanks to the rest of the organising committee for making this possible. Looking forward to a great meeting!

Yes great meeting. I had to leave but still have the pen you kindly lent me for the poster judging. I'll return it next Monday!

Coming to the end of a fantastic few days in Rome participating in the @benbedphar.bsky.social meeting at Sapienza University. Great discussions about progress and next steps for NRF2 pharmacology. Managed to squeeze in a Parkrun too! 🏃🏻‍♂️

New Centre for Excellence in Regulatory Science and Innovation in #Pharmacogenomics to help UK move towards personalised prescribing:

news.liverpool.ac.uk/2025/01/28/n...

@livunihls.bsky.social @livuni-ismib.bsky.social @innovateuk.bsky.social @ukri.org

Please add me Antonio

Nice to catch up as a group over lunch. Some great restaurant deals in January 😄

Are you a parent? Or caring for another adult, relative, friend? And are you a UK-based #academic? 🧪
We recently ran a survey (www.qualtrics.manchester.ac.uk/jfe/form/SV_...) to capture lived experiences - if you didn't complete the survey at the time, please do now. Please share w/ colleagues

"Dates for your diary 2025" and the British Pharmacological Logo on a faux-leather background with stationary and a sticker.

✨ Happy New Year! ✨ We hope your 2025 has got off to a fantastic start! To help you plan for the year ahead, we've compiled some key dates for your diary: www.bps.ac.uk/news/article... 🧪💊🗓

#Pharmacology #ClinicalPharmacology #Pharmacogenomics #STEM #STEMEvents

NF-κB is a Central Regulator of Hypoxia-Induced Gene Expression Hypoxia is both a physiological and pathological signal in cells. Changes in gene expression play a critical role in the cellular response to hypoxia, enabling cells to adapt to reduced oxygen availab...

Delighted to finally share our latest preprint on the role of NF-kappaB in hypoxia. Quite a few surprises!! www.biorxiv.org/content/10.1...
Have a look!

Done 👍🏻

All the best for 2025

My first 3 years as a TTF we're filled with grant rejections, including an MRC NIRG that I was devastated about. It's similar for many others, just not talked about as openly as the successes. Resilience is important in research. When you get that first break you can start to build some momentum.

...and we're hosting the British Toxicology Society annual meeting here in May, if you can make it. Details here: www.thebts.org/events/bts-a...

Sounds great. You should visit us in Liverpool when you're settled in Cambridge. Lots of folks here interested in drug and chemical toxicity. I'm sure they'd be interested to hear about your work.

As a recent recipient of this funding, I can highly recommend it as a means of broadening experiences and networks to support current and future research.

Have you heard about TherEx, #LivUni's Centre for Experimental Therapeutics?

The TherEx mission is to improve health and wellbeing by optimising the use of existing drugs and accelerating the development of new treatments.

Making medicines better.

➡️ www.liverpool.ac.uk/centre-for-e...

Nice Christmas lunch combining with several @livunihls.bsky.social groups. And yes, I know it's not even December yet!

MRC DiMeN Doctoral Training Partnership: Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans at University of Liverpool on FindAPhD.com PhD Project - MRC DiMeN Doctoral Training Partnership: Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans at University of Liverpool, listed ...

Fully funded MRC DiMeN PhD studentship available in my group starting October 2025. Come work with us in Liverpool!

Identification of accessible biomarkers reflecting drug stimulation of the NRF2 antioxidant pathway in humans

Deadline 13 December 2024

Informal enquiries welcome

Details here...

Done 👍🏻

Done 👍🏻

Done 👍🏻

Registration and abstract submission now open for the 2025 British Toxicology Society annual congress. Student and carer bursaries also available. Join us in May for a great meeting in Liverpool!

www.thebts.org/events/bts-a...

No, maybe you were recalling the trial that Evgen (now TheraCryf) are planning for their sulforaphane based drug: theracryf.com/pipeline/#sf...